New England Journal of Medicine, 0028-4793

Journal

  1. 2020
  2. Fenaux, P., Platzbecker, U., Mufti, G. J., Garcia-Manero, G., Buckstein, R., Santini, V., ... List, A. F. (2020). Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes. New England Journal of Medicine, 382(2), 140-151. https://doi.org/10.1056/NEJMoa1908892
  3. 2019
  4. Claassens, D. M. F., Vos, G. J. A., Bergmeijer, T. O., Hermanides, R. S., van 't Hof, A. W. J., van der Harst, P., ... ten Berg, J. M. (2019). A Genotype-Guided Strategy for Oral P2Y(12) Inhibitors in Primary PCI. New England Journal of Medicine, 381(17), 1621-1631. https://doi.org/10.1056/NEJMoa1907096
  5. CREDENCE Trial Investigators, Perkovic, V., Jardine, M. J., Neal, B., Bompoint, S., Heerspink, H. J. L., ... Mahaffey, K. W. (2019). Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. New England Journal of Medicine, 380(24), 2295-2306. https://doi.org/10.1056/NEJMoa1811744
  6. Steers, N. J., Li, Y., Drace, Z., D'Addario, J. A., Fischman, C., Liu, L., ... Kiryluk, K. (2019). Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection. New England Journal of Medicine, 380(20), 1918-1928. https://doi.org/10.1056/NEJMoa1803731
  7. RACE 7 ACWAS Investigators, Pluymaekers, N. A. H. A., Dudink, E. A. M. P., Luermans, J. G. L. M., Meeder, J. G., Lenderink, T., ... Crijns, H. J. G. M. (2019). Early or Delayed Cardioversion in Recent-Onset Atrial Fibrillation. New England Journal of Medicine, 380(16), 1499-1508. https://doi.org/10.1056/NEJMoa1900353
  8. Lemkes, J. S., Janssens, G. N., van der Hoeven, N. W., Jewbali, L. S. D., Dubois, E. A., Meuwissen, M., ... van Royen, N. (2019). Coronary Angiography after Cardiac Arrest without ST-Segment Elevation. New England Journal of Medicine, 380(15), 1397-1407. https://doi.org/10.1056/NEJMoa1816897
  9. LEAP Study Grp, Verschuur, C. V. M., Suwijn, S. R., Boel, J. A., Post, B., Bloem, B. R., ... de Bie, R. M. A. (2019). Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease. New England Journal of Medicine, 380(4), 315-324. https://doi.org/10.1056/NEJMoa1809983
  10. 2018
  11. SUP-ICU Trial Grp, Krag, M., Marker, S., Perner, A., Wetterslev, J., Wise, M. P., ... Dieperink, W. (2018). Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU. New England Journal of Medicine, 379(23), 2199-2208. https://doi.org/10.1056/NEJMoa1714919
  12. PALISADE Grp Clinical, Vickery, B. P., Vereda, A., Casale, T. B., Beyer, K., du Toit, G., ... Oude Elberink, J. N. G. (2018). AR101 Oral Immunotherapy for Peanut Allergy. New England Journal of Medicine, 379(21), 1991-2001. https://doi.org/10.1056/NEJMoa1812856
  13. Mutsaerts, M. A. Q., van Oers, A. M., Groen, H., Burggraaff, J. M., Kuchenbecker, W. K. H., Perquin, D. A. M., ... Hoek, A. (2018). Correction: Randomized Trial of a Lifestyle Program in Obese Infertile Women (vol 374, pg 1942, 2016). New England Journal of Medicine, 378(26), 2546-2546. https://doi.org/10.1056/NEJMx180013
  14. Carpenter, T. O., Whyte, M. P., Imel, E. A., Boot, A. M., Hogler, W., Linglart, A., ... Portale, A. A. (2018). Burosumab Therapy in Children with X-Linked Hypophosphatemia. New England Journal of Medicine, 378(21), 1987-1998. https://doi.org/10.1056/NEJMoa1714641
  15. van Driel, W. J., Koole, S. N., Sikorska, K., van Leeuwen, J. H. S., Schreuder, H. W. R., Hermans, R. H. M., ... Sonke, G. S. (2018). Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. New England Journal of Medicine, 378(3), 230-240. https://doi.org/10.1056/NEJMoa1708618
  16. 2017
  17. Torres, V. E., Chapman, A. B., Devuyst, O., Gansevoort, R. T., Perrone, R. D., Koch, G., ... REPRISE Trial Investigators (2017). Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease. New England Journal of Medicine, 377(20), 1930-1942. https://doi.org/10.1056/NEJMoa1710030
  18. Pavord, I. D., Chanez, P., Criner, G. J., Kerstjens, H. A. M., Korn, S., Lugogo, N., ... Sciurba, F. C. (2017). Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease. New England Journal of Medicine, 377(17), 1613-1629. https://doi.org/10.1056/NEJMoa1708208
  19. Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., ... CANVAS Program Collaborative Grp (2017). Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes. New England Journal of Medicine, 377(7), 644-657. https://doi.org/10.1056/NEJMoa1611925
  20. Stone, J. H., Tuckwell, K., Dimonaco, S., Klearman, M., Aringer, M., Blockmans, D., ... Collinson, N. (2017). Trial of Tocilizumab in Giant-Cell Arteritis. New England Journal of Medicine, 377(4), 317-328. https://doi.org/10.1056/NEJMoa1613849
  21. Afshin, A., Forouzanfar, M. H., Reitsma, M. B., Sur, P., Estep, K., Lee, A., ... GBD 2015 Obesity Collaborators (2017). Health Effects of Overweight and Obesity in 195 Countries over 25 Years. New England Journal of Medicine, 377(1), 13-27. https://doi.org/10.1056/NEJMoa1614362
  22. Carbone, D. P., Reck, M., Paz-Ares, L., Creelan, B., Horn, L., Steins, M., ... CheckMate 026 Investigators (2017). First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer. New England Journal of Medicine, 376(25), 2415-2426. https://doi.org/10.1056/NEJMoa1613493
  23. Faries, M. B., Thompson, J. F., Cochran, A. J., Andtbacka, R. H., Mozzillo, N., Zager, J. S., ... Elashoff, R. M. (2017). Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. New England Journal of Medicine, 376(23), 2211-2222. https://doi.org/10.1056/NEJMoa1613210
  24. Dreyer, K., van Rijswijk, J., Mijatovic, V., Goddijn, M., Verhoeve, H. R., van Rooij, I. A. J., ... Mol, B. W. J. (2017). Oil-Based or Water-Based Contrast for Hysterosalpingography in Infertile Women. New England Journal of Medicine, 376(21), 2043-2052. https://doi.org/10.1056/NEJMoa1612337
  25. Packer, M., O'Connor, C., McMurray, J. J. V., Wittes, J., Abraham, W. T., Anker, S. D., ... TRUE-AHF Investigators (2017). Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure. New England Journal of Medicine, 376(20), 1956-1964. https://doi.org/10.1056/NEJMoa1601895
  26. Steri, M., Orru, V., Idda, M. L., Pitzalis, M., Pala, M., Zara, I., ... Cucca, F. (2017). Overexpression of the Cytokine BAFF and Autoimmunity Risk. New England Journal of Medicine, 376(17), 1615-1626. https://doi.org/10.1056/NEJMoa1610528
  27. 2016
  28. Mirza, M. R., Monk, B. J., Herrstedt, J., Oza, A. M., Mahner, S., Redondo, A., ... ENGOT-OV16 NOVA Investigators (2016). Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. New England Journal of Medicine, 375(22), 2154-2164. https://doi.org/10.1056/NEJMoa1611310
  29. Guenther, G., Lange, C., Alexandru, S., Altet, N., Avsar, K., Bang, D., ... van Leth, F. (2016). Treatment Outcomes in Multidrug-Resistant Tuberculosis. New England Journal of Medicine, 375(11), 1103-1105. https://doi.org/10.1056/NEJMc1603274
  30. Gotlib, J., Kluin-Nelemans, H. C., George, T. I., Akin, C., Sotlar, K., Hermine, O., ... Reiter, A. (2016). Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis. New England Journal of Medicine, 374(26), 2530-2541. https://doi.org/10.1056/NEJMoa1513098
  31. Mutsaerts, M. A. Q., van Oers, A. M., Groen, H., Burggraaff, J. M., Kuchenbecker, W. K. H., Perquin, D. A. M., ... Hoek, A. (2016). Randomized Trial of a Lifestyle Program in Obese Infertile Women. New England Journal of Medicine, 374(20), 1941-1952. https://doi.org/10.1056/NEJMoa1505297
  32. McGeachie, M. J., Yates, K. P., Zhou, X., Guo, F., Sternberg, A. L., Van Natta, M. L., ... CAMP Res Grp (2016). Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. New England Journal of Medicine, 374(19), 1842-1852. https://doi.org/10.1056/NEJMoa1513737
  33. Laghmani, K., Beck, B. B., Yang, S-S., Seaayfan, E., Wenzel, A., Reusch, B., ... Koemhoff, M. (2016). Polyhydramnios, Transient Antenatal Bartter's Syndrome, and MAGED2 Mutations. New England Journal of Medicine, 374(19), 1853-1863. https://doi.org/10.1056/NEJMoa1507629
  34. 2015
  35. Schaapveld, M., Aleman, B. M. P., van Eggermond, A. M., Janus, C. P. M., Krol, A. D. G., van der Maazen, R. W. M., ... van Leeuwen, F. E. (2015). Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma. New England Journal of Medicine, 373(26), 2499-2511. https://doi.org/10.1056/NEJMoa1505949
  36. Coomarasamy, A., Williams, H., Truchanowicz, E., Seed, P. T., Small, R., Quenby, S., ... Rai, R. (2015). A Randomized Trial of Progesterone in Women with Recurrent Miscarriages. New England Journal of Medicine, 373(22), 2141-2148. https://doi.org/10.1056/NEJMoa1504927
  37. Pollack, C. V., Reilly, P. A., Eikelboom, J., Glund, S., Verhamme, P., Bernstein, R. A., ... Weitz, J. I. (2015). Idarucizumab for Dabigatran Reversal. New England Journal of Medicine, 373(6), 511-520. https://doi.org/10.1056/NEJMoa1502000
  38. Lauby-Secretan, B., Scoccianti, C., Loomis, D., Benbrahim-Tallaa, L., Bouvard, V., Bianchini, F., ... International Agency for Research on Cancer Handbook Working Group (2015). Breast-cancer screening--viewpoint of the IARC Working Group. New England Journal of Medicine, 372(24), 2353-2358. https://doi.org/10.1056/NEJMsr1504363
Previous 1 2 3 4 5 6 Next

ID: 1520896